Literature DB >> 3371407

Characterisation of the ATP4- receptor that mediates permeabilisation of rat mast cells.

P E Tatham1, N J Cusack, B D Gomperts.   

Abstract

ATP (as the tetrabasic acid, ATP4-) applied externally to rat mast cells causes the formation of lesions which permit influx and efflux of low molecular weight, normally impermeant aqueous solutes. To monitor membrane permeabilisation we have used two fluorescent dyes, ethidium which stains the nucleus, and TMA-DPH which stains the cytosolic surfaces of intracellular membranes following entry into the cells Permeabilisation by ATP is not affected by the metabolic status of the cells, and is maintained at temperatures as low as 8 degrees C. We have tested the ability of 30 structural analogues of ATP to effect mast cell permeabilisation. The analogues include those having substituents in the 2- and 8-positions of the purine ring, structural and optical isomers of the ribose sugar, and variations in the triphosphate chain. The pattern of selectivity displayed by the rat mast cell ATP4- receptor is distinct from those characteristic of the P1 purinoceptor for adenosine and the P2X and P2Y purinoceptors for adenine nucleotides.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3371407     DOI: 10.1016/0014-2999(88)90628-0

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  25 in total

1.  P2X7 receptor-pannexin 1 hemichannel association: effect of extracellular calcium on membrane permeabilization.

Authors:  V Poornima; M Madhupriya; S Kootar; G Sujatha; Arvind Kumar; Amal Kanti Bera
Journal:  J Mol Neurosci       Date:  2011-09-20       Impact factor: 3.444

2.  Functional characterisation of P2 purinoceptors in PC12 cells by measurement of radiolabelled calcium influx.

Authors:  A D Michel; C B Grahames; P P Humphrey
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-11       Impact factor: 3.000

3.  G-proteins as targets for non-immunological histamine releasers.

Authors:  M Mousli; J L Bueb; B Rouot; Y Landry; C Bronner
Journal:  Agents Actions       Date:  1991-05

4.  Selective permeabilization of cervical cancer cells to an ionic DNA-binding cytotoxin by activation of P2Y receptors.

Authors:  Maurish Bukhari; Han Deng; Noelle Jones; Zachary Towne; Craig D Woodworth; Damien S K Samways
Journal:  FEBS Lett       Date:  2015-05-01       Impact factor: 4.124

5.  Acute paw oedema formation induced by ATP: re-evaluation of the mechanisms involved.

Authors:  L E Ziganshina; A U Ziganshin; C H Hoyle; G Burnstock
Journal:  Inflamm Res       Date:  1996-02       Impact factor: 4.575

6.  Antagonist effects on human P2X(7) receptor-mediated cellular accumulation of YO-PRO-1.

Authors:  A D Michel; R Kaur; I P Chessell; P P Humphrey
Journal:  Br J Pharmacol       Date:  2000-06       Impact factor: 8.739

7.  Physical basis of apparent pore dilation of ATP-activated P2X receptor channels.

Authors:  Mufeng Li; Gilman E S Toombes; Shai D Silberberg; Kenton J Swartz
Journal:  Nat Neurosci       Date:  2015-09-21       Impact factor: 24.884

8.  Novel P2X7 receptor antagonists ease the pain.

Authors:  B F King
Journal:  Br J Pharmacol       Date:  2007-04-30       Impact factor: 8.739

9.  P2X7 receptors regulate multiple types of membrane trafficking responses and non-classical secretion pathways.

Authors:  Yan Qu; George R Dubyak
Journal:  Purinergic Signal       Date:  2009-02-03       Impact factor: 3.765

10.  Evidence that a form of ATP uncomplexed with divalent cations is the ligand of P2y and nucleotide/P2u receptors on aortic endothelial cells.

Authors:  S Motte; S Pirotton; J M Boeynaems
Journal:  Br J Pharmacol       Date:  1993-08       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.